|
1
|
Sanni OB, Mc Menamin ÚC, Cardwell CR,
Sharp L, Murray LJ and Coleman HG: Commonly used medications and
endometrial cancer survival: A population-based cohort study. Br J
Cancer. 117:432–438. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pautier P and Pommeret F: Systemic therapy
for advanced endometrial cancer. Bull Cancer. 104:1046–1053.
2017.In French. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ballester M, Bendifallah S and Daraï E:
European guidelines (ESMO-ESGO-ESTRO consensus conference) for the
management of endometrial cancer. Bull Cancer. 104:1032–1038.
2017.In French. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stope MB, Koensgen D, Weimer J, Paditz M,
Burchardt M, Bauerschlag D and Mustea A: The future therapy of
endometrial cancer: microRNA's functionality, capability, and
putative clinical application. Arch Gynecol Obstet. 294:889–895.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramón LA, Braza-Boïls A, Gilabert J,
Chirivella M, España F, Estellés A and Gilabert-Estellés J:
microRNAs related to angiogenesis are dysregulated in endometrioid
endometrial cancer. Hum Reprod. 27:3036–3045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park YA, Lee JW, Choi JJ, Jeon HK, Cho Y,
Choi C, Kim TJ, Lee NW, Kim BG and Bae DS: The interactions between
MicroRNA-200c and BRD7 in endometrial carcinoma. Gynecol Oncol.
124:125–133. 2012. View Article : Google Scholar
|
|
8
|
Chung TK, Cheung TH, Huen NY, Wong KW, Lo
KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, et al: Dysregulated
microRNAs and their predicted targets associated with endometrioid
endometrial adenocarcinoma in Hong Kong women. Int J Cancer.
124:1358–1365. 2009. View Article : Google Scholar
|
|
9
|
Li BL, Lu W, Lu C, Qu JJ, Yang TT, Yan Q
and Wan XP: CpG island hypermethylation-associated silencing of
microRNAs promotes human endometrial cancer. Cancer Cell Int.
13:442013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai Y, Xia W, Song T, Su X, Li J, Li S,
Chen Y, Wang W, Ding H, Liu X, et al: MicroRNA-200b is
overexpressed in endometrial adenocarcinomas and enhances MMP2
activity by downregulating TIMP2 in human endometrial cancer cell
line HEC-1A cells. Nucleic Acid Ther. 23:29–34. 2013. View Article : Google Scholar :
|
|
11
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hendriks SH, Schrijnders D, van Hateren
KJ, Groenier KH, Siesling S, Maas AHEM, Landman GWD, Bilo HJG and
Kleefstra N: Association between body mass index and
obesity-related cancer risk in men and women with type 2 diabetes
in primary care in the Netherlands: A cohort study (ZODIAC-56). BMJ
Open. 8:e0188592018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Flannery CA, Saleh FL, Choe GH, Selen DJ,
Kodaman PH, Kliman HJ, Wood TL and Taylor HS: Differential
expression of IR-A, IR-B and IGF-1R in endometrial physiology and
distinct signature in adenocarcinoma. J Clin Endocrinol Metab.
101:2883–2891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P,
Zhang Q, Dong L, Liu Y and Dong J: [Corrigendum] MicroRNA-320a
inhibits tumor invasion by targeting neuropilin 1 and is associated
with liver metastasis in colorectal cancer. Oncol Rep. 33:20932015.
View Article : Google Scholar
|
|
16
|
Yao J, Liang LH, Zhang Y, Ding J, Tian Q,
Li JJ and He XH: GNAI1 suppresses tumor cell migration and invasion
and is post-transcriptionally regulated by Mir-320a/c/d in
hepatocellular carcinoma. Cancer Biol Med. 9:234–241. 2012.
|
|
17
|
van der Kolk JH, Pacholewska A and Gerber
V: The role of microRNAs in equine medicine: A review. Vet Q.
35:88–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Shi C, Wang J, Cao L, Zhong L and
Wang D: MicroRNA-320a is downregulated in non-small cell lung
cancer and suppresses tumor cell growth and invasion by directly
targeting insulin-like growth factor 1 receptor. Oncol Lett.
13:3247–3252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo T, Feng Y, Liu Q, Yang X, Jiang T,
Chen Y and Zhang Q: MicroRNA-320a suppresses in GBM patients and
modulates glioma cell functions by targeting IGF-1R. Tumour Biol.
35:11269–11275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sianou A, Galyfos G, Moragianni D,
Andromidas P, Kaparos G, Baka S and Kouskouni E: The role of
microRNAs in the pathogenesis of endometrial cancer: A systematic
review. Arch Gynecol Obstet. 292:271–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carroll AP, Goodall GJ and Liu B:
Understanding principles of miRNA target recognition and function
through integrated biological and bioinformatics approaches. Wiley
Interdiscip Rev RNA. 5:361–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diakos C, Zhong S, Xiao Y, Zhou M,
Vasconcelos GM, Krapf G, Yeh RF, Zheng S, Kang M, Wiencke JK, et
al: TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and
miRNA-320a. Blood. 116:4885–4893. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bronisz A, Godlewski J, Wallace JA,
Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ,
Martin CK, Li F, et al: Reprogramming of the tumour
microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol.
14:159–167. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen L, Zheng J, Zhang Y, Yang L, Wang J,
Ni J, Cui D, Yu C and Cai Z: Tumor-specific expression of
microRNA-26a suppresses human hepatocellular carcinoma growth via
cyclin-dependent and -independent pathways. Mol Ther. 19:1521–1528.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huse JT, Brennan C, Hambardzumyan D, Wee
B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T
and Holland EC: The PTEN-regulating microRNA miR-26a is amplified
in high-grade glioma and facilitates gliomagenesis in vivo. Genes
Dev. 23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shu S, Yang Y, Li X, Li T, Zhang Y, Xu C,
Liang C and Wang X: Down-regulation of IGF-1R expression inhibits
growth and enhances chemosensitivity of endometrial carcinoma in
vitro. Mol Cell Biochem. 353:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shu S, Li X, Yang Y, Zhang Y, Li T, Liang
C and Wan J: Inhibitory effect of siRNA targeting IGF-1R on
endometrial carcinoma. Int Immunopharmacol. 11:244–249. 2011.
View Article : Google Scholar
|
